AVXL ▲ +6.7% - Anavex Life Sciences Corp.
$AVXL - Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome
15-OCT-2026 04:00 PM ET
Share this post
More filings for $AVXL
AVXL ▼ -2.1% - Anavex Life Sciences Corp.Sep 24, 2026AVXL ▲ +0.4% - Anavex Life Sciences Corp.Sep 14, 2026AVXL ▼ -1.7% - Anavex Life Sciences Corp.Sep 8, 2026AVXL ▲ +0.7% - Anavex Life Sciences Corp.Sep 2, 2026$AVXL SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $AVXL filing history →💬 Comments
Loading comments…
Leave a comment